- Home
- AMBC vs INBX Comparison
AMBC vs INBX Comparison
Compare AMBC & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMBC
- INBX
- Stock Information
- Founded
- AMBC 1971
- INBX 2010
- Country
- AMBC United States
- INBX United States
- Employees
- AMBC N/A
- INBX N/A
- Industry
- AMBC Property-Casualty Insurers
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- AMBC Finance
- INBX Health Care
- Exchange
- AMBC Nasdaq
- INBX Nasdaq
- Market Cap
- AMBC 411.3M
- INBX 345.8M
- IPO Year
- AMBC 1991
- INBX 2020
- Fundamental
- Price
- AMBC $8.68
- INBX $26.71
- Analyst Decision
- AMBC Strong Buy
- INBX Hold
- Analyst Count
- AMBC 2
- INBX 2
- Target Price
- AMBC $12.50
- INBX N/A
- AVG Volume (30 Days)
- AMBC 578.9K
- INBX 111.3K
- Earning Date
- AMBC 11-11-2025
- INBX 11-13-2025
- Dividend Yield
- AMBC N/A
- INBX N/A
- EPS Growth
- AMBC N/A
- INBX N/A
- EPS
- AMBC N/A
- INBX N/A
- Revenue
- AMBC $257,879,000.00
- INBX $1,400,000.00
- Revenue This Year
- AMBC N/A
- INBX N/A
- Revenue Next Year
- AMBC $19.44
- INBX N/A
- P/E Ratio
- AMBC N/A
- INBX N/A
- Revenue Growth
- AMBC 148.44
- INBX N/A
- 52 Week Low
- AMBC $5.99
- INBX $10.81
- 52 Week High
- AMBC $13.64
- INBX $30.23
- Technical
- Relative Strength Index (RSI)
- AMBC 51.60
- INBX 54.46
- Support Level
- AMBC N/A
- INBX $27.51
- Resistance Level
- AMBC $9.28
- INBX $28.86
- Average True Range (ATR)
- AMBC 0.27
- INBX 1.44
- MACD
- AMBC -0.38
- INBX -0.28
- Stochastic Oscillator
- AMBC 92.73
- INBX 31.85
About AMBC Ambac Financial Group Inc.
Ambac Financial Group Inc is a financial services holding company. It operates in two principal businesses segments: Insurance Distribution and Specialty Property & Casualty Insurance. Insurance Distribution segment includes Managing General Agents, Underwriters and other appointed and delegated underwriting businesses (collectively MGAs or MGA/Us), an insurance broker, and other distribution and underwriting businesses. Specialty Property & Casualty Insurance includes five carriers (collectively, Everspan). Key revenue is generated from Insurance Distribution.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.